Nanogen, Inc. is an advanced diagnostics company with the ability to address customer needs spanning the research, clinical reference laboratory, and point-of-care markets. The drive towards personalizing patient care is just beginning, and the development of increasingly sophisticated medical research and diagnostics will create improvements in healthcare. Nanogen’s technologies are uniquely bridging the gap between early-stage scientific research and actual clinical practice. Nanogen, Inc. acquired Epoch Biosciences in Q4 2004.